Barclays’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12M Buy
184,639
+45,359
+33% +$2.96M ﹤0.01% 1051
2025
Q1
$9.32M Sell
139,280
-17,780
-11% -$1.19M ﹤0.01% 1059
2024
Q4
$8.68M Buy
157,060
+14,027
+10% +$775K ﹤0.01% 1211
2024
Q3
$8.53M Buy
143,033
+135,003
+1,681% +$8.05M ﹤0.01% 1132
2024
Q2
$511K Sell
8,030
-6,852
-46% -$436K ﹤0.01% 2523
2024
Q1
$1.03M Sell
14,882
-10,383
-41% -$717K ﹤0.01% 2388
2023
Q4
$1.39M Buy
25,265
+15,944
+171% +$879K ﹤0.01% 2396
2023
Q3
$541K Buy
9,321
+1,682
+22% +$97.6K ﹤0.01% 2503
2023
Q2
$411K Buy
7,639
+498
+7% +$26.8K ﹤0.01% 2724
2023
Q1
$283K Buy
7,141
+595
+9% +$23.6K ﹤0.01% 2970
2022
Q4
$264K Buy
6,546
+2,193
+50% +$88.4K ﹤0.01% 2956
2022
Q3
$140K Sell
4,353
-2,999
-41% -$96.5K ﹤0.01% 3257
2022
Q2
$218K Sell
7,352
-4,460
-38% -$132K ﹤0.01% 3078
2022
Q1
$331K Sell
11,812
-4,154
-26% -$116K ﹤0.01% 3040
2021
Q4
$736K Buy
15,966
+8,190
+105% +$378K ﹤0.01% 2353
2021
Q3
$255K Buy
7,776
+2,525
+48% +$82.8K ﹤0.01% 2871
2021
Q2
$185K Sell
5,251
-11,365
-68% -$400K ﹤0.01% 2924
2021
Q1
$601K Buy
16,616
+1,230
+8% +$44.5K ﹤0.01% 2565
2020
Q4
$447K Sell
15,386
-995
-6% -$28.9K ﹤0.01% 2376
2020
Q3
$462K Buy
16,381
+2,988
+22% +$84.3K ﹤0.01% 2346
2020
Q2
$433K Buy
13,393
+916
+7% +$29.6K ﹤0.01% 2400
2020
Q1
$509K Sell
12,477
-1,336
-10% -$54.5K ﹤0.01% 2114
2019
Q4
$852K Buy
13,813
+4,626
+50% +$285K ﹤0.01% 2398
2019
Q3
$669K Sell
9,187
-3,275
-26% -$238K ﹤0.01% 2467
2019
Q2
$1.02M Sell
12,462
-11,453
-48% -$940K ﹤0.01% 2310
2019
Q1
$1.69M Sell
23,915
-268
-1% -$18.9K ﹤0.01% 1684
2018
Q4
$1.09M Buy
24,183
+8,834
+58% +$397K ﹤0.01% 1765
2018
Q3
$868K Buy
15,349
+5,381
+54% +$304K ﹤0.01% 2338
2018
Q2
$665K Sell
9,968
-1,292
-11% -$86.2K ﹤0.01% 2105
2018
Q1
$655K Buy
11,260
+685
+6% +$39.8K ﹤0.01% 2095
2017
Q4
$681K Buy
10,575
+3,715
+54% +$239K ﹤0.01% 1876
2017
Q3
$361K Buy
6,860
+3,078
+81% +$162K ﹤0.01% 2091
2017
Q2
$176K Sell
3,782
-1,815
-32% -$84.5K ﹤0.01% 2509
2017
Q1
$277K Sell
5,597
-3,670
-40% -$182K ﹤0.01% 2314
2016
Q4
$562K Buy
9,267
+5,931
+178% +$360K ﹤0.01% 1777
2016
Q3
$221K Sell
3,336
-17,931
-84% -$1.19M ﹤0.01% 2090
2016
Q2
$1.19M Buy
21,267
+9,852
+86% +$550K ﹤0.01% 1368
2016
Q1
$378K Sell
11,415
-14,654
-56% -$485K ﹤0.01% 1831
2015
Q4
$1.17M Buy
26,069
+9,707
+59% +$437K ﹤0.01% 1283
2015
Q3
$639K Buy
16,362
+3,235
+25% +$126K ﹤0.01% 1612
2015
Q2
$813K Sell
13,127
-7,511
-36% -$465K ﹤0.01% 1579
2015
Q1
$1.28M Buy
20,638
+19,703
+2,107% +$1.22M ﹤0.01% 1486
2014
Q4
$52K Sell
935
-3,181
-77% -$177K ﹤0.01% 2993
2014
Q3
$115K Buy
4,116
+3,588
+680% +$100K ﹤0.01% 2575
2014
Q2
$18K Sell
528
-849
-62% -$28.9K ﹤0.01% 3448
2014
Q1
$43K Buy
1,377
+732
+113% +$22.9K ﹤0.01% 3237
2013
Q4
$13K Sell
645
-16
-2% -$322 ﹤0.01% 3855
2013
Q3
$6K Sell
661
-150
-18% -$1.36K ﹤0.01% 3752
2013
Q2
$5K Buy
+811
New +$5K ﹤0.01% 4054